Veeva Systems Inc.

NYSE:VEEV

Medical - Healthcare Information Services

Healthcare
$277.20 -1.83%

-$2.83 today

Market cap
$44.88B
Beta
0.95
P/E (TTM)
26.4
EPS (TTM)
$5.76
52W Low $148.05High $310.50

Volume 2.74M

Average 3.01M

VEEV Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Veeva Systems Inc.NYSE: VEEV

Net Margin · Q2 FY2027 · quarter ended Jul 2026

Net margin widens to 29.5%

Net margin was 29.5% in Q2 FY2027, up 4.1 pp from a year earlier. On a trailing-twelve-month basis it was 29.3%, up 2.1 pp year over year. Over 3 fiscal years it widened by 5.8 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.
  • FY2026 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 21 analysts of 41.8% for the fiscal year ending Jan 2027, up from 28.4% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJul 2026
29.5%-0.1 pp QoQ
Last fiscal yearJan 2026
28.4%+2.4 pp YoY
LTMJul 2026
29.3%+2.1 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+4.1 pp+12.2 pp+8.1 pp
1 year+2.4 pp+13.3 pp+10.9 pp
3 years+5.8 pp+12.2 pp+6.4 pp
5 years+13.0 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2026
28.4%
Year-over-year change
+2.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How VEEV compares with its peers on the latest reported figures

  • VEEV's LTM Jul 2026 net margin of 29.3% is the highest of the 5 companies compared; the peer median is 7.2%.
  • Its year-over-year change of +2.1 pp is the 2nd highest of 5, against a peer median of +0.0 pp.
  • Over three fiscal years its change of +5.8 pp compares with a peer median of +2.5 pp.
VEEV Competitors Peer median
Net Margin for VEEV and competitors
Company Period LTM level YoY 3-year change
VEEVVeeva Systems Inc.LTM Jul 202629.3% +2.1 pp+5.8 pp
DOCSDoximity, Inc.LTM Sep 202621.1% -19.6 pp+3.5 pp
IQVIQVIA Holdings Inc.LTM Jun 20268.1% +0.2 pp+0.8 pp
HSTMHealthStream, Inc.LTM Mar 20266.4% -0.1 pp+1.5 pp
SDGRSchrödinger, Inc.LTM Sep 2026-22.0% +46.5 pp+42.1 pp
Peer median (excluding VEEV) 7.2%+0.0 pp+2.5 pp

Competitors are the stored peer set for VEEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jan 2022
FY2023
Jan 2023
FY2024
Jan 2024
FY2025
Jan 2025
FY2026
Jan 2026
Revenue1.85B2.16B2.36B2.75B3.2B
Cost of Revenue503.68M609.41M677.29M699.64M782.02M
Gross Profit1.35B1.55B1.69B2.05B2.41B
Gross Margin72.8%71.7%71.3%74.5%75.5%
Research & Development382.04M520.28M629.03M693.08M767.39M
Selling, General & Admin459.57M566.29M628.02M662.47M729.54M
Operating Expenses841.6M1.09B1.26B1.36B1.5B
Depreciation & Amortization27.45M29.12M32.63M39.38M50.47M
EBITDA539.76M538.22M620.65M958.76M1.24B
EBITDA Margin29.2%25.0%26.3%34.9%39.0%
Operating Income505.5M459.09M429.33M691.44M916.37M
Operating Margin27.3%21.3%18.2%25.2%28.7%
Interest Income14.73M45.86M133.75M207.99M0
Interest Expense00000
Other Income / Expenses6.82M50.01M158.69M227.95M278.14M
Income Before Tax512.31M509.1M588.02M919.38M1.19B
Pre-Tax Margin27.7%23.6%24.9%33.5%37.4%
Income Tax Expense84.92M21.39M62.32M205.24M285.6M
Net Income427.39M487.71M525.71M714.14M908.91M
Net Margin23.1%22.6%22.2%26.0%28.4%
EPS (Basic)2.793.143.274.415.55
EPS (Diluted)2.633.003.224.325.44
Weighted Avg Shares153.25M155.39M160.53M161.88M163.67M
Weighted Avg Shares (Diluted)162.28M162.44M163.49M165.23M167M

Veeva Systems Inc.

NYSE:VEEV

Intrinsic Alpha fair value

Locked

Current Price

$277.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.